Optimal Sensing in Atrial Tachyarrhythmia's Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 111 participants.

Also called NCT01074749

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 111 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01074749
Other papers using this trial's data
  • Enhanced detection of atrial tachyarrhythmias with pacing devices by using more accurate atrial sensing Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2022-04 DOI, PubMed 34599455, PMC9151574 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01074749. Randomized; single masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2014-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Optimal Sensing in Atrial Tachyarrhythmia's Study
Acronym
OSAT
Condition
Sick Sinus Syndrome
Condition
Paroxysmal Atrial Fibrillation
Intervention (Device)
Accent Pacemaker
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct01074749
Content hash
c11a55a888c2580e86b5d3e83342aa07fba731885f7719be4b0b0cd970e00ef9